Off-treatment durability of antiviral response to nucleoside analogues in patients with chronic hepatitis B

Off-treatment durability of nucleoside analogue (NA) therapy in patients with chronic hepatitis B has not been well investigated. In this study we monitored antiviral effect of NA therapy and evaluated off-treatment durability after NA cessation in patients with chronic hepatitis B. A total of 94 co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC gastroenterology 2016-03, Vol.16 (38), p.38, Article 38
Hauptverfasser:	Nagata, Naruhiko, Kagawa, Tatehiro, Hirose, Shunji, Arase, Yoshitaka, Tsuruya, Kota, Anzai, Kazuya, Shiraishi, Koichi, Mine, Tetsuya
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Alanine Transaminase - blood Antiviral Agents - therapeutic use Carcinoma, Hepatocellular - epidemiology Care and treatment Cohort Studies Development and progression Disease Progression DNA, Viral - blood Female Follow-Up Studies Gastroenterology Guanine - analogs & derivatives Guanine - therapeutic use Health aspects Hepatitis B Hepatitis B e Antigens - blood Hepatitis B Surface Antigens - blood Hepatitis B, Chronic - blood Hepatitis B, Chronic - drug therapy Humans Inflammation Lamivudine Lamivudine - therapeutic use Liver Neoplasms - epidemiology Male Middle Aged Polymerase Chain Reaction Recurrence Remission Induction Retrospective Studies Reverse Transcriptase Inhibitors - therapeutic use Risk factors Viral Load
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!